Table of contents
STRATEGIC EVALUATION
SWOT ANALYSIS
Strengths
Weaknesses
Opportunities
Threats
PROSPECTS FOR THE OTC HEALTHCARE BUSINESS
Capitalise on the valuable sectors
Geographic expansion
Rx-to-OTC switches
Challenged by increased risk on business integration
Table 1 Novartis AG: World Sector Sales Performance by Value 2005
Table 2 Novartis AG: OTC Healthcare Regional Sales Performance by Value 2005
CORPORATE OVERVIEW
STRATEGIC OBJECTIVES AND CHALLENGES
Dynamic growth through focused business, geographic expansion and more acquisitions
Speeding up operation in emerging Asia-Pacific
Facing the challenge of increasing distribution costs
OPERATIONAL AND DISTRIBUTION STRATEGIES
OWNERSHIP EVENTS
PIPELINE
Summary 1 Novartis AG: Key Facts
PERFORMANCE BY REGION AND BY SECTOR
OTC HEALTHCARE MARKET ASSESSMENT
ANALGESICS
Competitive landscape
Prospects
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Competitive landscape
Prospects
DIGESTIVE REMEDIES
Competitive landscape
Prospects
MEDICATED SKIN CARE
Competitive landscape
Prospects
VITAMINS AND DIETARY SUPPLEMENTS
Competitive landscape
Prospects
NRT SMOKING CESSATION AIDS
Competitive landscape
Prospects
EYE CARE
Competitive landscape
Prospects
CALMING AND SLEEPING PRODUCTS
Competitive landscape
Prospects
WOUND TREATMENT
Competitive landscape
Prospects
ADULT MOUTHCARE
Competitive landscape
Prospects
Table 3 Novartis AG: World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 4 Novartis AG: World and Regional Shares in OTC Healthcare by Sector by Value 2005
BRAND ASSESSMENT
BRAND STRATEGY
Global brands identified within extensive portfolio
Acquisitions to broaden portfolio
Innovate to expand brand families
Developing through product switches
LAMISIL
MAALOX
NICOTINELL
TRIAMINIC
VOLTAREN
Table 5 Novartis AG: Lamisil World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 6 Novartis AG: Lamisil Regional Shares in OTC Healthcare by Sector by Value 2005
Table 7 Novartis AG: Maalox World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 8 Novartis AG: Maalox Regional Shares in OTC Healthcare by Sector by Value 2005
Table 9 Novartis AG: Nicotinell World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 10 Novartis AG: Nicotinell Regional Shares in OTC Healthcare by Sector by Value 2005
Table 11 Novartis AG: Triaminic World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 12 Novartis AG: Triaminic Regional Shares in OTC Healthcare by Sector by Value 2005
Table 13 Novartis AG: Voltaren World Shares & Rankings in OTC Healthcare by Sector by Value 2004-2005
Table 14 Novartis AG: Voltaren Regional Shares in OTC Healthcare by Sector by Value 2005
APPENDICES
FINANCIAL SUMMARY
Table 15 Novartis AG: Financial Summary 2001-2005
COMPANY BACKGROUND
Summary 2 Novartis AG: Historical Development
Summary 3 Novartis AG: Subsidiaries 2005
Summary 4 Novartis AG: OTC Healthcare Brands 2005
Summary 5 Novartis AG: Company locations
Summary 6 Novartis AG: Websites
For more information, Please visit :
http://www.bharatbook.com/
